Tianjin Minxiang Pharmaceutical

Tianjin Minxiang Pharmaceutical is a specialized pharmaceutical company based in China that focuses on the development and manufacturing of active pharmaceutical ingredients (APIs) and high-end intermediates. The company is a dominant global player in the production of the amantadine series, including amantadine hydrochloride and rimantadine hydrochloride, which are critical for treating influenza A and Parkinson's disease. Beyond antivirals, Minxiang produces memantine hydrochloride for the treatment of Alzheimer's disease and various other small molecule therapeutics. Their operations are supported by large-scale GMP-compliant manufacturing facilities and a dedicated R&D center in the Tianjin Economic-Technological Development Area. The company serves a broad international clientele, providing both catalog products and custom manufacturing services (CMO/CDMO).